|
End-of-day quote
Nasdaq
14/10/2026
|
5-day change | 1st Jan Change | ||
| 16.00 USD | 0.00% |
|
0.00% | - |
| 09:03pm | Iambic Therapeutics Shares Rise in Nasdaq Debut | MT |
| 10-14 | Iambic Therapeutics, Inc. has completed an IPO in the amount of $150 million. | CI |
| 1 week | 16 |  | 16 |
| 1 month | 16 | | 16 |
| Current year | 16 | | 16 |
| 1 year | 16 | | 16 |
| 3 years | 16 | | 16 |
| 5 years | 16 | | 16 |
| 10 years | 16 | | 16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Miller
CEO | Chief Executive Officer | 48 | 01/01/2020 |
Frederick Manby
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/2020 |
Michael Secora
DFI | Director of Finance/CFO | 44 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frederick Manby
BRD | Director/Board Member | 54 | 01/01/2020 |
| Director/Board Member | 78 | 01/03/2023 | |
| Director/Board Member | 48 | 01/07/2021 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.19M 1.07M 991K 901K 1.7M 113M 1.73M 11.9M 4.66M 59M 4.48M 4.39M 189M | 9.43M 8.41M 7.82M 7.11M 13.38M 893M 13.62M 93.93M 36.75M 466M 35.37M 34.62M 1.49B |
| Net income | -47.88M -42.74M -39.72M -36.13M -67.97M -4.53B -69.2M -477M -187M -2.37B -180M -176M -7.57B | -77.3M -68.99M -64.12M -58.33M -110M -7.32B -112M -770M -301M -3.82B -290M -284M -12.22B |
| Net Debt | - | - |
Employees
171
Sector
-
| Date | Price | Change |
|---|---|---|
| 14/10/26 | $16.00 | 0.00% |
- Stock Market
- Stocks
- IAM Stock
Select your edition
All financial news and data tailored to specific country editions
